litlas
ログインアカウント作成

John M. Goldman

1974–2013 年に発表

143
論文数
43,465
被引用数
103
h 指数
143
i10 指数

被引用数

John M. Goldman の年別被引用数1975 年: 被引用 1 件1976 年: 被引用 4 件1977 年: 被引用 1 件1978 年: 被引用 1 件1979 年: 被引用 15 件1980 年: 被引用 5 件1981 年: 被引用 10 件1982 年: 被引用 8 件1983 年: 被引用 8 件1984 年: 被引用 16 件1985 年: 被引用 10 件1986 年: 被引用 10 件1987 年: 被引用 12 件1988 年: 被引用 19 件1989 年: 被引用 37 件1990 年: 被引用 40 件1991 年: 被引用 31 件1992 年: 被引用 41 件1993 年: 被引用 53 件1994 年: 被引用 58 件1995 年: 被引用 59 件1996 年: 被引用 50 件1997 年: 被引用 54 件1998 年: 被引用 71 件1999 年: 被引用 120 件2000 年: 被引用 145 件2001 年: 被引用 192 件2002 年: 被引用 370 件2003 年: 被引用 413 件2004 年: 被引用 326 件2005 年: 被引用 303 件2006 年: 被引用 324 件2007 年: 被引用 384 件2008 年: 被引用 346 件2009 年: 被引用 360 件2010 年: 被引用 382 件2011 年: 被引用 365 件2012 年: 被引用 354 件2013 年: 被引用 331 件2014 年: 被引用 314 件2015 年: 被引用 286 件2016 年: 被引用 272 件2017 年: 被引用 198 件2018 年: 被引用 151 件2019 年: 被引用 634 件2020 年: 被引用 521 件2021 年: 被引用 423 件2022 年: 被引用 335 件2023 年: 被引用 164 件2024 年: 被引用 337 件2025 年: 被引用 114 件2026 年: 被引用 2 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,867 件、この内訳の 30.2%イギリス: 引用元論文 841 件、この内訳の 8.9%ドイツ: 引用元論文 702 件、この内訳の 7.4%イタリア: 引用元論文 570 件、この内訳の 6%フランス: 引用元論文 526 件、この内訳の 5.6%中国: 引用元論文 387 件、この内訳の 4.1%オーストラリア: 引用元論文 302 件、この内訳の 3.2%カナダ: 引用元論文 279 件、この内訳の 2.9%スイス: 引用元論文 269 件、この内訳の 2.8%日本: 引用元論文 265 件、この内訳の 2.8%オランダ: 引用元論文 256 件、この内訳の 2.7%スペイン: 引用元論文 226 件、この内訳の 2.4%
0%30.2%その他 21%

機関

分野

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Immunology and Microbiology4.3%
  • Computer Science0.7%
  • Mathematics0.5%
  • Chemistry0.5%
  • その他2.3%

トピック

  • Chronic Myeloid Leukemia Treatments13.1%
  • Chronic Lymphocytic Leukemia Research6.9%
  • Eosinophilic Disorders and Syndromes5.9%
  • Acute Myeloid Leukemia Research5.2%
  • Hematopoietic Stem Cell Transplantation4.8%
  • Acute Lymphoblastic Leukemia research3.2%
  • その他60.9%

共著者

全論文

検索で開く
  1. A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    著者: Jörge E. Cortes, D. W. Kim, Javier Pinilla‐Ibarz, Philipp le Coutre, Ronald Paquette, Charles Chuah, Franck E. Nicolini, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, John F. DiPersio, Daniel J. DeAngelo, Elisabetta Abruzzese, Delphine Réa, Michele Baccarani, Martin C. Müller, Carlo Gambacorti‐Passerini, Siu‐Fun Wong, Stephanie Lustgarten, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, François Guilhot, Michael W. Deininger, Andreas Hochhaus, Timothy P. Hughes, John M. Goldman, Neil P. Shah, Hagop M. Kantarjian - New England Journal of Medicine 2013 被引用: 1,124

  2. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

    著者: Brian Druker, François Guilhot, Stephen G. O’Brien, Insa Gathmann, Hagop M. Kantarjian, Norbert Gattermann, Michael W. Deininger, Richard T. Silver, John M. Goldman, Richard M. Stone, Francisco Cervantes, Andreas Hochhaus, Bayard L. Powell, Janice Gabrilove, Philippe Rousselot, Josy Reiffers, Jan J. Cornelissen, Timothy P. Hughes, Hermine Agis, Thomas Fischer, Gregor Verhoef, John D. Shepherd, Giuseppe Saglio, Aloïs Gratwohl, Johan Lanng Nielsen, Jerald P. Radich, Bengt Simonsson, Kerry Taylor, Michele Baccarani, Charlene So, Laurie Letvak, Richard A. Larson - New England Journal of Medicine 2006 被引用: 3,481

  3. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

    著者: Stephen G. O’Brien, François Guilhot, Richard A. Larson, Insa Gathmann, Michele Baccarani, Francisco Cervantes, Jan J. Cornelissen, Thomas Fischer, Andreas Hochhaus, Timothy P. Hughes, Klaus Lechner, Johan Lanng Nielsen, Philippe Rousselot, Josy Reiffers, Giuseppe Saglio, John D. Shepherd, Bengt Simonsson, Aloïs Gratwohl, John M. Goldman, Hagop M. Kantarjian, Kerry Taylor, Gregor Verhoef, Ann E. Bolton, Renaud Capdeville, Brian Druker - New England Journal of Medicine 2003 被引用: 3,565

  4. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    著者: Michele Baccarani, Michael Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F. Apperley, Francisco Cervantes, Richard E. Clark, Jörge E. Cortes, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, Hagop M. Kantarjian, Dong‐Wook Kim, Richard A. Larson, Jeffrey H. Lipton, François-Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin Müller, Dietger Niederwieser, Fabrizio Pane, Jerald P. Radich, Philippe Rousselot, Giuseppe Saglio, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Juan-Luis Steegmann, John M. Goldman, Rüdiger Hehlmann - Blood 2013 被引用: 1,989

  5. The molecular biology of chronic myeloid leukemia

    著者: Michael W. Deininger, John M. Goldman, Junia V. Melo - Blood 2000 被引用: 1,620

  6. Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

    著者: Aristeidis Chaidos, Scott D. Patterson, Richard Szydlo, Mohammed S. Chaudhry, Francesco Dazzi, Edward Kanfer, Donald M. McDonald, David Marin, Dragana Milojković, Jiří Pavlů, John Davis, Amin Rahemtulla, Katy Rezvani, John M. Goldman, Irene Roberts, Jane F. Apperley, Anastasios Karadimitris - Blood 2012 被引用: 162

  7. Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

    著者: David Marín, Alexandra Bazeos, François-Xavier Mahon, Lina Eliasson, Dragana Milojković, Marco Bua, Jane F. Apperley, Richard Szydlo, Ritti Desai, Kasia Kozlowski, Christos Paliompeis, Victoria Latham, Letizia Foroni, Mathiéu Molimard, Alistair Reid, Katy Rezvani, Hugues de Lavallade, Cristina Guallar, John M. Goldman, Jamshid S. Khorashad - Journal of Clinical Oncology 2010 被引用: 901

  8. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    著者: Michele Baccarani, Jörge E. Cortes, Fabrizio Pane, Dietger Niederwieser, Giuseppe Saglio, Jane F. Apperley, Francisco Cervantes, Michael W. Deininger, Aloïs Gratwohl, François Guilhot, Andreas Hochhaus, Mary M. Horowitz, Timothy P. Hughes, Hagop M. Kantarjian, Richard A. Larson, Jerald P. Radich, Bengt Simonsson, Richard T. Silver, John M. Goldman, Rüdiger Hehlmann - Journal of Clinical Oncology 2009 被引用: 1,298

  9. Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia

    著者: Timothy P. Hughes, Jaspal Kaeda, Susan Branford, Zbigniew Rudzki, Andreas Hochhaus, Martee L. Hensley, Insa Gathmann, Ann E. Bolton, Iris C. van Hoomissen, John M. Goldman, Jerald P. Radich - New England Journal of Medicine 2003 被引用: 1,222

  10. Regulation of myeloid leukaemia by the cell-fate determinant Musashi

    著者: Takahiro Ito, Hyog Young Kwon, Bryan Zimdahl, Kendra L. Congdon, Jordan Blum, William Lento, Chen Zhao, Anand S. Lagoo, Gareth Gerrard, Letizia Foroni, John M. Goldman, Harriet Goh, Soo Hyun Kim, Dong‐Wook Kim, Charles Chuah, Vivian G. Oehler, Jerald P. Radich, Craig T. Jordan, Tannishtha Reya - Nature 2010 被引用: 366

  11. Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis

    著者: Hugues de Lavallade, Jane F. Apperley, Jamshid S. Khorashad, Dragana Milojković, Alistair Reid, Marco Bua, Richard Szydlo, Eduardo Olavarría, Jaspal Kaeda, John M. Goldman, David Marín - Journal of Clinical Oncology 2008 被引用: 556

  12. Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors

    著者: David Marín, Amr R. Ibrahim, Claire Lucas, Gareth Gerrard, Lihui Wang, Richard Szydlo, Richard E. Clark, Jane F. Apperley, Dragana Milojković, Marco Bua, Jiří Pavlů, Christos Paliompeis, Alistair Reid, Katayoun Rezvani, John M. Goldman, Letizia Foroni - Journal of Clinical Oncology 2011 被引用: 475

  13. Reorganizing patient care and workflow in the operating room: a cost-effectiveness study

    著者: J.‐P. Stahl, Warren S. Sandberg, Bethany Daily, Richard A. Wiklund, M.F. Egan, John M. Goldman, Keith Isaacson, Scott Gazelle, David W. Rattner - Surgery 2006 被引用: 140

  14. Hematology: basic principles and practice

    著者: John M. Goldman - Bone Marrow Transplantation 2013 被引用: 497

  15. Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

    著者: Timothy P. Hughes, Andreas Hochhaus, Susan Branford, Martin C. Müller, Jaspal Kaeda, Letizia Foroni, Brian Druker, François Guilhot, Richard A. Larson, Stephen G. O’Brien, Marc S. Rudoltz, Manisha Mone, Elisabeth Wehrle, Vijay Modur, John M. Goldman, Jerald P. Radich, on behalf of the IRIS investigators - Blood 2010 被引用: 487

  16. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers

    著者: Mark Cobbold, Naeem Khan, Batoul Pourgheysari, Sudhir Tauro, Dorothy McDonald, Husam Osman, Mario Assenmacher, Lucinda Billingham, Colin G. Steward, Charles Crawley, Eduardo Olavarría, John M. Goldman, Ronjon Chakraverty, Premini Mahendra, Charles Craddock, Paul Moss - The Journal of Experimental Medicine 2005 被引用: 477

  17. Chronic myeloid leukemia: mechanisms of blastic transformation

    著者: Danilo Perrotti, Catriona Jamieson, John M. Goldman, Tomasz Skórski - Journal of Clinical Investigation 2010 被引用: 395

  18. Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy

    著者: Amr R. Ibrahim, Lina Eliasson, Jane F. Apperley, Dragana Milojković, Marco Bua, Richard Szydlo, François‐Xavier Mahon, Kasia Kozlowski, Christos Paliompeis, Letizia Foroni, Jamshid S. Khorashad, A. Bazeos, Mathiéu Molimard, Alistair Reid, Katayoun Rezvani, Gareth Gerrard, John M. Goldman, David Marín - Blood 2011 被引用: 316

  19. Identical-Twin Bone Marrow Transplants for Leukemia

    著者: Robert Peter Gale, Mary M. Horowitz, Robert C. Ash, Richard E. Champlin, John M. Goldman, Alfred A. Rimm, Olle Ringden, Judith A. Veum Stone, Mortimer M. Bortin - Annals of Internal Medicine 1994 被引用: 288

  20. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

    著者: Paolo Neviani, Jason G. Harb, Joshua J. Oaks, Ramasamy Santhanam, Christopher J. Walker, Justin J. Ellis, Gregory Ferenchak, Adrienne M. Dorrance, Carolyn Paisie, Anna M. Eiring, Yihui Ma, Hsiaoyin Mao, Bin Zhang, Mark Wunderlich, Philippa C. May, Chaode Sun, Sahar A. Saddoughi, Jacek Bielawski, William Blum, Rebecca B. Klisovic, Janelle A. Solt, John C. Byrd, Stefano Volinia, Jörge E. Cortes, Claudia S. Huettner, Steffen Koschmieder, Tessa L. Holyoake, Steven M. Devine, Michael A. Caligiuri, Carlo M. Croce, Ramiro Garzon, Besim Öğretmen, Ralph B. Arlinghaus, Ching-Shih Chen, Robert Bittman, Peter Hokland, Denis-Claude Roy, Dragana Milojković, Jane F. Apperley, John M. Goldman, Alistair Reid, James C. Mulloy, Ravi Bhatia, Guido Marcucci, Danilo Perrotti - Journal of Clinical Investigation 2013 被引用: 219

  21. Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL–negative chronic myeloproliferative disorders

    著者: Marianna Dávid, Nicholas C.P. Cross, Sonja Burgstaller, Andrew Chase, Claire Curtis, Raymond Dang, Martine Gardembas, John M. Goldman, Francis Grand, George S. Hughes, Françoise Huguet, Louise Lavender, Grant A. McArthur, François Xavier Mahon, Giorgio Massimini, Junia V. Melo, Philippe Rousselot, R. Russell‐Jones, John F. Seymour, Graeme Smith, Alastair Stark, Katherine Waghorn, Zariana Nikolova, Jane F. Apperley - Blood 2006 被引用: 173

  22. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

    著者: Andreas Hochhaus, S G O'Brien, François Guilhot, Brian Druker, Susan Branford, Letizia Foroni, John M. Goldman, Martin Müller, Jerald P. Radich, Marc S. Rudoltz, Manisha Mone, Insa Gathmann, Timothy P. Hughes, Richard A. Larson, for the IRIS Investigators - Leukemia 2009 被引用: 845

  23. Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

    著者: Jane F. Apperley, Martine Gardembas, Junia V. Melo, R. Russell‐Jones, Barbara J. Bain, E. Joanna Baxter, Andrew Chase, Judith M. Chessells, Marie Colombat, Claire Dearden, Saša Dimitrijević, François-X. Mahon, David Marin, Zariana Nikolova, Eduardo Olavarría, Sandra Silberman, Beate Schultheis, Nicholas C.P. Cross, John M. Goldman - New England Journal of Medicine 2002 被引用: 631

  24. MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

    著者: François‐Xavier Mahon, Françis Belloc, Valérie Lagarde, Claudine Chollet, François Moreau‐Gaudry, Josy Reiffers, John M. Goldman, Junia V. Melo - Blood 2003 被引用: 538